Related Experiment Videos
CD10 plays a specific role in early thymic development
1CJF INSERM 96.05, Activation des Cellules Hematopoietique, Faculté de Médecine, Nice, France.
Summary
Inhibiting the ectopeptidase CD10 (endopeptidase 24.11) disrupts T lymphocyte development. This enzyme is crucial for the differentiation of thymocytes into mature T cells, impacting early T cell development.
Area of Science:
- Immunology
- Molecular Biology
- Enzymology
Background:
- T lymphocyte development is a complex process involving cell interactions and soluble factors.
- Ectopeptidases, like CD10 (endopeptidase 24.11), regulate local peptide concentrations in tissues.
Purpose of the Study:
- To investigate the role of CD10 (endopeptidase 24.11) in T lymphocyte development.
- To determine the effect of CD10 inhibition on thymocyte differentiation.
Main Methods:
- Treatment of fetal thymic organ cultures (FTOC) with CD10 inhibitors (SCH 32615, RB25, thymopentin).
- Analysis of thymocyte populations (CD4+CD8+, TN, CD44+CD25-, CD44-CD25-) in vitro and in vivo.
- In vivo administration of RB25 to pregnant mice.
Main Results:
- CD10 inhibition significantly decreased double positive (CD4+CD8+) thymocytes and increased TN cells.
- RB25 blocked T lymphocyte differentiation in FTOC, both in vitro and after maternal administration.
- RB25 and thymopentin reduced CD44+CD25- and CD44-CD25- thymocyte populations.
Conclusions:
- The ectopeptidase CD10 (endopeptidase 24.11) plays a specific role in promoting early T cell development.
- Inhibiting CD10 activity impairs T lymphocyte development both in vitro and in vivo.